Evidence Synthesis
VIVIDM Sees Acceleration in Gross Margin and Revenue Growth, Despite Declining Marginal Operating Leverage.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 4 Sept 2026, 15:19
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
VIVIDM Sees Acceleration in Gross Margin and Revenue Growth, Despite Declining Marginal Operating Leverage.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 17.74 % | -121.94 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -121.94 % | 21.31 | ▼ |
| REVENUE_GROWTH_YOY | 22.7 % | -58.3 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 53,504 shares | 2,64,191 | ▼ |
| CLOSE_PRICE | 5.56 INR | 5.56 | - |